Table of contents
Volume 100, Issue 5
Published online 3 March 2009 (671-864)
Clinical Studies |
Translational Therapeutics |
Molecular Diagnostics |
Epidemiology |
Letter to the Editor |
Book Review
Review
CYP17 blockade by abiraterone: further evidence for frequent continued hormone-dependence in castration-resistant prostate cancer
J E Ang, D Olmos and J S de Bono
Br J Cancer 100: 671-675; advance online publication, February 17, 2009; doi:10.1038/sj.bjc.6604904
Clinical Studies
The expression of RUNX3 in colorectal cancer is associated with disease stage and patient outcome
R Soong, N Shah, B K Peh, P Y Chong, S S Ng, N Zeps, D Joseph, M Salto-Tellez, B Iacopetta and Y Ito
Br J Cancer 100: 676-679; advance online publication, February 17, 2009; doi:10.1038/sj.bjc.6604899
Poor survival outcomes in HER2-positive breast cancer patients with low-grade, node-negative tumours
S M Tovey, S Brown, J C Doughty, E A Mallon, T G Cooke and J Edwards
Br J Cancer 100: 680-683; advance online publication, February 17, 2009; doi:10.1038/sj.bjc.6604940
Management of cardiac health in trastuzumab-treated patients with breast cancer: updated United Kingdom National Cancer Research Institute recommendations for monitoring FREE
A L Jones, M Barlow, P J Barrett-Lee, P A Canney, I M Gilmour, S D Robb, C J Plummer, A M Wardley and M W Verrill
Br J Cancer 100: 684-692; doi:10.1038/sj.bjc.6604909
The impact of 18-fluorodeoxyglucose positron emission tomography on the staging, management and outcome of anal cancer
E de Winton, A G Heriot, M Ng, R J Hicks, A Hogg, A Milner, T Leong, M Fay, J MacKay, E Drummond and S Y Ngan
Br J Cancer 100: 693-700; doi:10.1038/sj.bjc.6604897
Comparison of tumour-based (Petersen Index) and inflammation-based (Glasgow Prognostic Score) scoring systems in patients undergoing curative resection for colon cancer
C S D Roxburgh, J E M Crozier, F Maxwell, A K Foulis, J Brown, R F McKee, J H Anderson, P G Horgan and D C McMillan
Br J Cancer 100: 701-706; advance online publication, February 10, 2009; doi:10.1038/sj.bjc.6604926
Extended weekly dose-dense paclitaxel/carboplatin is feasible and active in heavily pre-treated platinum-resistant recurrent ovarian cancer
R Sharma, J Graham, H Mitchell, A Brooks, S Blagden and H Gabra
Br J Cancer 100: 707-712; advance online publication, February 17, 2009; doi:10.1038/sj.bjc.6604914
Translational Therapeutics
Dietary supplementation with a specific combination of high protein, leucine, and fish oil improves muscle function and daily activity in tumour-bearing cachectic mice
K van Norren, D Kegler, J M Argilés, Y Luiking, M Gorselink, A Laviano, K Arts, J Faber, H Jansen, E M van der Beek and A van Helvoort
Br J Cancer 100: 713-722; doi:10.1038/sj.bjc.6604905
Protoporphyrin IX enhancement by 5-aminolaevulinic acid peptide derivatives and the effect of RNA silencing on intracellular metabolism
L Bourré, F Giuntini, I M Eggleston, M Wilson and A J MacRobert
Br J Cancer 100: 723-731; advance online publication, February 24, 2009; doi:10.1038/sj.bjc.6604928
Biomarker analysis in stage III–IV (M0) gastric cancer patients who received curative surgery followed by adjuvant 5-fluorouracil and cisplatin chemotherapy: epidermal growth factor receptor (EGFR) associated with favourable survival
J-S Kim, M-A Kim, T M Kim, S-H Lee, D-W Kim, S-A Im, T-Y Kim, W H Kim, H-K Yang, D S Heo, Y-J Bang, K-U Lee, K-J Choe and N K Kim
Br J Cancer 100: 732-738; doi:10.1038/sj.bjc.6604936
Apollon gene silencing induces apoptosis in breast cancer cells through p53 stabilisation and caspase-3 activation
A Lopergolo, M Pennati, P Gandellini, N I Orlotti, P Poma, M G Daidone, M Folini and N Zaffaroni
Br J Cancer 100: 739-746; advance online publication, February 17, 2009; doi:10.1038/sj.bjc.6604927
Treatment regimen determines whether an HIF-1 inhibitor enhances or inhibits the effect of radiation therapy
H Harada, S Itasaka, Y Zhu, L Zeng, X Xie, A Morinibu, K Shinomiya and M Hiraoka
Br J Cancer 100: 747-757; advance online publication, February 17, 2009; doi:10.1038/sj.bjc.6604939
Combined inhibition of DNA methylation and histone acetylation enhances gene re-expression and drug sensitivity in vivo
N Steele, P Finn, R Brown and J A Plumb
Br J Cancer 100: 758-763; doi:10.1038/sj.bjc.6604932
Molecular Diagnostics
Overexpression of E2F-5 correlates with a pathological basal phenotype and a worse clinical outcome FREE
S Umemura, M Shirane, S Takekoshi, T Kusakabe, J Itoh, N Egashira, Y Tokuda, K Mori and Y R Osamura
Br J Cancer 100: 764-771; doi:10.1038/sj.bjc.6604900
Abstract | Full Text | PDF | Supplementary information
HIF-1
determines the metastatic potential of gastric cancer cells
N Rohwer, S Lobitz, K Daskalow, T Jöns, M Vieth, P M Schlag, W Kemmner, B Wiedenmann, T Cramer and M Höcker
Br J Cancer 100: 772-781; advance online publication, February 17, 2009; doi:10.1038/sj.bjc.6604919
Relation between outcomes and localisation of p-mTOR expression in gastric cancer
T Murayama, M Inokuchi, Y Takagi, H Yamada, K Kojima, J Kumagai, T Kawano and K Sugihara
Br J Cancer 100: 782-788; advance online publication, February 17, 2009; doi:10.1038/sj.bjc.6604915
Taurine: a potential marker of apoptosis in gliomas
K S Opstad, B A Bell, J R Griffiths and F A Howe
Br J Cancer 100: 789-794; advance online publication, February 17, 2009; doi:10.1038/sj.bjc.6604933
Epidemiology
Does type 2 diabetes influence the risk of oesophageal adenocarcinoma?
R E Neale, J D Doecke, N Pandeya, S Sadhegi, A C Green, P M Webb and D C Whiteman for The Australian Cancer Study
Br J Cancer 100: 795-798; advance online publication, February 3, 2009; doi:10.1038/sj.bjc.6604908
Trends in the incidence of primary liver cancer in Central Uganda, 1960–1980 and 1991–2005
P Ocama, S Nambooze, C K Opio, M S Shiels, H R Wabinga and G D Kirk
Br J Cancer 100: 799-802; advance online publication, January 27, 2009; doi:10.1038/sj.bjc.6604893
Birth characteristics and risk of colorectal cancer: a study among Swedish twins
S Cnattingius, F Lundberg and A Iliadou
Br J Cancer 100: 803-806; advance online publication, February 17, 2009; doi:10.1038/sj.bjc.6604918
Is the biology of breast cancer changing? A study of hormone receptor status 1984–1986 and 1996–1997
S B F Brown, E A Mallon, J Edwards, F M Campbell, L M McGlynn, B Elsberger and T G Cooke
Br J Cancer 100: 807-810; advance online publication, February 17, 2009; doi:10.1038/sj.bjc.6604934
Radiation to supraclavicular and internal mammary lymph nodes in breast cancer increases the risk of stroke
G Nilsson, L Holmberg, H Garmo, A Terent and C Blomqvist
Br J Cancer 100: 811-816; doi:10.1038/sj.bjc.6604902
Breast cancer risk in elderly women with systemic autoimmune rheumatic diseases: a population-based case–control study
S M Gadalla, S Amr, P Langenberg, M Baumgarten, W F Davidson, C Schairer, E A Engels, R M Pfeiffer and J J Goedert
Br J Cancer 100: 817-821; advance online publication, February 3, 2009; doi:10.1038/sj.bjc.6604906
Risks of myeloid malignancies in patients with autoimmune conditions
L A Anderson, R M Pfeiffer, O Landgren, S Gadalla, S I Berndt and E A Engels
Br J Cancer 100: 822-828; doi:10.1038/sj.bjc.6604935
Cancer risk in hospitalised asthma patients
J Ji, X Shu, X Li, K Sundquist, J Sundquist and K Hemminki
Br J Cancer 100: 829-833; advance online publication, January 27, 2009; doi:10.1038/sj.bjc.6604890
Urinary tract infections and reduced risk of bladder cancer in Los Angeles
X Jiang, J E Castelao, S Groshen, V K Cortessis, D Shibata, D V Conti, J-M Yuan, M C Pike and M Gago-Dominguez
Br J Cancer 100: 834-839; advance online publication, January 27, 2009; doi:10.1038/sj.bjc.6604889
Pattern of cancer risk in persons with AIDS in Italy in the HAART era
L Dal Maso, J Polesel, D Serraino, M Lise, P Piselli, F Falcini, A Russo, T Intrieri, M Vercelli, P Zambon, G Tagliabue, R Zanetti, M Federico, R M Limina, L Mangone, V De Lisi, F Stracci, S Ferretti, S Piffer, M Budroni, A Donato, A Giacomin, F Bellù, M Fusco, A Madeddu, S Vitarelli, R Tessandori, R Tumino, B Suligoi and S Franceschi for the Cancer and AIDS Registries Linkage (CARL) Study
Br J Cancer 100: 840-847; advance online publication, February 17, 2009; doi:10.1038/sj.bjc.6604923
Tobacco chewing and female oral cavity cancer risk in Karunagappally cohort, India
P A Jayalekshmi, P Gangadharan, S Akiba, R R K Nair, M Tsuji and B Rajan
Br J Cancer 100: 848-852; doi:10.1038/sj.bjc.6604907
Unchanged incidence and increased survival in children with neuroblastoma in Denmark 1981–2000: a population-based study
H Schroeder, J Wacher, H Larsson, S Rosthoej, C Rechnitzer, B L Pedersen and N L T Carlsen
Br J Cancer 100: 853-857; advance online publication, February 17, 2009; doi:10.1038/sj.bjc.6604922
Cancer survival discrepancies in developed and developing countries: comparisons between the Philippines and the United States
M T Redaniel, A Laudico, M R Mirasol-Lumague, A Gondos, D Pulte, C Mapua and H Brenner
Br J Cancer 100: 858-862; advance online publication, February 24, 2009; doi:10.1038/sj.bjc.6604945
Letter to the Editor
Infections in early life and risk of childhood ALL
M Greaves and P A Buffler
Br J Cancer 100: 863; doi:10.1038/sj.bjc.6604950
Book Review
Apoptosis, senescence and cancer (cancer drug discovery and development)
A Young
Br J Cancer 100: 864; doi:10.1038/sj.bjc.6604944
The published online date indicates the date that the issue is published online and is the first official publication date of the issue. Each print issue of BJC is published one week after it has been published online.
